Clinique de Genolier

Dr. med. Laëtitia Lestrade

Spécialiste FMH en Radio-oncologie

Sprachen
FR EN IT

Kontakt

Klinik (1)

Clinique de Genolier
Route du Muids 3
1272 Genolier

Berufserfahrung

seit 2020

Médecin Radio-oncologue pour la Clinique de Genolier

2016 - 2020

Médecin cadre en Radio-oncologie, Centre Hospitalo-universitaire de Besançon

2013 - 2016

Cheffe de clinique en Radio-oncologie, Hôpitaux Universitaires de Genève

2012 - 2013

Médecin assistant Fellow en Radio-oncologie, ASST Papa Giovanni XXIII Bergamo

2007 - 2012

Médecin interne (Radio-oncologie, Oncologie, Pneumologie, Hépato-gastro-entérologie, Médecine nucléaire), Hospices Civils de Lyon

Publikationen

Modern intensity-modulated radiotherapy with image guidance allows low toxicity rates and good local control in chemoradiotherapy for anal cancer patients. De Bari B, Lestrade L, Franzetti-Pellanda A, Jumeau R, Biggiogero M, Kountouri M, Matzinger O, Miralbell R, Bourhis J, Ozsahin M, Zilli T. 2018

Single French centre retrospective analysis of local control after high dose radiotherapy with or without chemotherapy and local control for Pancoast tumours. De Bari B, Lestrade L, Souquet PJ, Pacheco Y, Geriniere L, Guibert B, Mornex F. 2012

Adult prostatic sarcoma: A contemporary multicenter Rare Cancer Network study. De Bari B, Stish B, Ball MW, Habboush Y, Sargos P, Krengli M, Bossi A, Stabile A, Sole Pesutic C, Lestrade L, Smeenk RJ, Jereczek-Fossa BA, Zilli T, Créhange G, Alongi F, Zaorsky N, Ozsahin M. 2017 

Should the treatment of anal carcinoma be adapted in the elderly? A retrospective analysis of acute toxicities in a French centre and a review of the literature.

De Bari B, Lestrade L, Chekrine T, Shakir Shakir I, Ardiet JM, Chapet O, Mornex F. 2012 

Primitive Squamous Cell Carcinoma of Pterygopalatine Fossa. Mauvais O, Badet C, Lestrade L, Tavernier L. 2018

Impact of hydrogel spacer injections on interfraction prostate motion during prostate cancer radiotherapy. Picardi C, Rouzaud M, Kountouri M, Lestrade L, Vallée JP, Caparrotti F, Dubouloz A, Miralbell R, Zilli T. 2016 

Role of brachytherapy in the treatment of cancers of the anal canal. Long-term follow-up and multivariate analysis of a large monocentric retrospective series. Lestrade L, De Bari B, Pommier P, Montbarbon X, Lavergne E, Ardiet JM, Carrie C. 2014

Setup margins and geometric uncertainties in intensity-modulated radiation therapy in treating pituitary adenomas: the experience of Lyon Sud Hospital. De Bari B, Shakir Shakir I, Chekrine T, Lestrade L, Favrel V. 2012

Radiochemotherapy and brachytherapy could be the standard treatment for anal canal cancer in elderly patients? A retrospective single-centre analysis. Lestrade L, De Bari B, Montbarbon X, Pommier P, Carrie C. 2013

External beam radiotherapy ± chemotherapy in the treatment of anal canal cancer: a single-institute long-term experience on 100 patients. De Bari B, Buglione M, Maddalo M, Lestrade L, Spiazzi L, Vitali P, Barbera F, Magrini SM. 2014

Early-stage Favourable Anal Cancer: A Retrospective Analysis of Clinical Outcomes of a Moderately Low Dose Elective Nodal Intensity-modulated Radiotherapy Schedule. Lestrade L, Zilli T, Kountouri M, Jumeau R, Matzinger O, Bourhis J, Miralbell R, Ozsahin M, De Bari B. 2017

Patterns of Failure in Patients With Head and Neck Squamous Cell Carcinomas of Unknown Primary Treated With Chemoradiotherapy. Dhouib F, Bertaut A, Maingon P, Siala W, Daoud J, Aubignac L, Lestrade L, Crehange G, Vulquin. 2020

Could concomitant radio-chemotherapy improve the outcomes of early-stage node negative anal canal cancer patients? A retrospective analysis of 122 patients. De Bari B, Lestrade L, Pommier P, Maddalo M, Buglione M, Magrini SM, Carrie C. 2015

The Pocketable Electronic Devices in Radiation Oncology (PEDRO) Project: How the Use of Tools in Medical Decision Making is Changing? De Bari B, Franco P, Niyazi M, Cornetto AP, Qvortrup C, Martin AN, Cacicedo J, Fernandez G, Louro LV, Lestrade L, Ciammella P, Greto D, Checkrine T, Youssef E, Filippi AR, Poulsen LØ, Alongi F; Italian Association of Radiation Oncology-Young Members Working Group; Young German Society of Radiation Oncology; Spanish Young Radiation Oncology Group; Spanish Society of Radiation Oncology; Portuguese Society of Radiotherapy and Oncology-Young Members Working Group; SPRO Jovem; Danish Association of Young Oncologists. 2016

Ausbildung

2019

Diplôme d’Etude Spécialisée Complémentaire en cancérologie, Université Claude Bernard Lyon 1

2018

Diplôme Universitaire de radiothérapie des cancers ORL, Université Paris XI

2013

Reconnaissance du titre post-grade fédéral de médecin spécialiste en Radio-oncologie par la Fédération médicale helvétique

2007 - 2012

Diplôme d’étude spécialisé en Oncologie option Radiothérapie,  Université Claude Bernard Lyon 1

2001 - 2007

Etude de Médecine, Université Claude Bernard Lyon 1 - Hospices Civils de Lyon

Ärzte mit dieser Spezialisierung

Clinique Générale-Beaulieu

Dr. med. Odile Fargier-Bochaton

Spezialisierung
Radio-Onkologie
Clinique de Genolier

Dr. med. Adrien Cosinschi

Spezialisierung
Radio-Onkologie, CyberKnife® System, Radixact
Clinique de Genolier

Prof. Dr. med. Oscar Matzinger

Spezialisierung
Radio-Onkologie, CyberKnife® System, Radixact
Privatklinik Bethanien

Dr. med. Cristina Picardi

Spezialisierung
Radio-Onkologie, Innere Medizin, Papillon
Clinique de Genolier

Dr. med. Stéphane Nevesny

Spezialisierung
Radio-Onkologie
Clinique Générale-Beaulieu

Dr. med. Francesca Caparrotti

Spezialisierung
Radio-Onkologie, CyberKnife® System, Radixact, Papillon Mehr anzeigen